| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/26/2001 | EP1135378A1 Benzamide derivatives and their use as apob-100 secretion inhibitors |
| 09/26/2001 | EP1135374A1 Benzimidazole compounds that are vitronectin receptor antagonists |
| 09/26/2001 | EP1135359A1 Derivatives of (-)-venlafaxine and methods of preparing and using the same |
| 09/26/2001 | EP1135358A1 Derivatives of (+)-venlafaxine and methods of preparing and using the same |
| 09/26/2001 | EP1135155A1 Methods of inhibiting ectopic calcification |
| 09/26/2001 | EP1135153A1 Uses for eph receptor antagonists and agonists to treat vascular disorders |
| 09/26/2001 | EP1135151A1 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors |
| 09/26/2001 | EP1135139A1 Micronized eplerenone compositions |
| 09/26/2001 | EP1135131A1 Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants |
| 09/26/2001 | EP1135126A2 Myt1 kinase inhibitors |
| 09/26/2001 | EP1135123A1 Use of isatin derivatives as ion channel activating agents |
| 09/26/2001 | EP1135106A1 Sustained release matrix systems for highly soluble drugs |
| 09/26/2001 | EP0775141B1 Phenyl xanthine derivatives |
| 09/26/2001 | EP0767796B1 Chemotactic protein |
| 09/26/2001 | CN1314948A Targeted adenovirus vectors for delivery of heterologous genes |
| 09/26/2001 | CN1314912A Tartrate salt of a sabstituted dipentide as growth hormone secretagogue |
| 09/26/2001 | CN1314910A Adenosine derivatives |
| 09/26/2001 | CN1314904A Alkynyl-substituted quinoline-2-one derivatives useful as anticancer agents |
| 09/26/2001 | CN1314893A IL-8 receptor antanonists |
| 09/26/2001 | CN1314887A Ester of (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol and their use as prodrugs of the 5HT2A receptor antagonist MDL 110,907 |
| 09/26/2001 | CN1314884A 2,5-substituted benzoluslfonylureas and thioureas, methods for production thereof, use thereof and pharamceutical preparations containing the same |
| 09/26/2001 | CN1314883A Amino acid derivatives and drug containing the same as the active ingredient |
| 09/26/2001 | CN1314882A NAALADase inhibitors useful as pharmaceutical compound and compositions |
| 09/26/2001 | CN1314352A Soya aglycone-3'-sodium sulfonate and its preparing method and medicinal use |
| 09/26/2001 | CN1314345A Novel piperidine-4-sulfamide compound, its preparing method and medicinal composition containing them |
| 09/26/2001 | CN1314180A Scutellaria root extract with nerve protection and medicinal preparation containing said extract |
| 09/26/2001 | CN1314177A Medicine for treating high blood pressure and preventing cerebral hemorrhage and its preparing method |
| 09/26/2001 | CN1314155A Mampalon perfume and its producing method |
| 09/26/2001 | CN1314154A Traditional Chinese medicine external preparation for curing piles |
| 09/26/2001 | CN1314151A Use of AFMK in preparing medicine with free radical cloaning function |
| 09/26/2001 | CN1071760C N-terminally chemically modified protein composition and methods |
| 09/26/2001 | CN1071759C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and use thereof |
| 09/26/2001 | CN1071755C Heterocyclyycarboxamide derivatives and their use as therapeutic agents |
| 09/26/2001 | CN1071752C Substituted thiophenesulfonylureas and-thioureas, processes for thei preparation, their use as medicament or diagnostic, and medicament containing them |
| 09/26/2001 | CN1071743C Sulfuryl or sulfufiny/benzoyl guanidine derivative |
| 09/26/2001 | CN1071740C Nitro-benzamides useful as anti-arrhythmic agents |
| 09/26/2001 | CN1071578C Pharamceutical compositions and uses therefor |
| 09/26/2001 | CN1071573C Anti-atteroscherotic use of 17 alpha-dihydroeoquilin |
| 09/26/2001 | CN1071570C Extended release, film-coated table of astemizole and pseudoephedrine |
| 09/25/2001 | US6294675 Chemical intermediate |
| 09/25/2001 | US6294674 Dibenzofuran sulfonamide matrix metalloproteinase inhibitors |
| 09/25/2001 | US6294661 Compounds |
| 09/25/2001 | US6294580 For therapy and prophylaxis of type ii or non-insulin dependent diabetes mellitus, hyperglycaemia, dyslipidemia, type ii diabetes, type i diabetes, hypertriglyceridemia, syndrome x, insulin resistance, heart failure |
| 09/25/2001 | US6294566 Imidazoline derivatives and uses thereof |
| 09/25/2001 | US6294564 Benzimidazoles and benzoxazoles |
| 09/25/2001 | US6294562 Salts of ethyl 3-(2-(4-(4-amino-imino-methyl)phenyl)-4-methyl-2,5-dioxo-imidazolidin-1-yl)acetylamino)-3-phenylpropionate |
| 09/25/2001 | US6294561 Cyclic AMP-specific phosphodiesterase inhibitors |
| 09/25/2001 | US6294552 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 09/25/2001 | US6294550 Treatment of female sexual dysfunction |
| 09/25/2001 | US6294546 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 09/25/2001 | US6294542 Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 09/25/2001 | US6294538 Antidiabetic agents and diabetic neuropathy, treatment with oxidoreductase enzymes |
| 09/25/2001 | US6294533 Calcium channel blockers |
| 09/25/2001 | US6294525 Reverse-turn mimetics and methods relating thereto |
| 09/25/2001 | US6294522 Compounds for treatment of cardiovascular disorders |
| 09/25/2001 | US6294517 Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use |
| 09/25/2001 | US6294350 Methods for treating fibroproliferative diseases |
| 09/25/2001 | US6294201 Core, comprising 15 to 35% in weight of a pharmaceutically active substance; 20 to 50% in weight of xanthan; 10 to 30% in weight of a vinyl pyrrolidone--vinyl acetate copolymer |
| 09/25/2001 | US6294197 Known to be effective in the treatment of congestive heart failure and reducing blood pressure. |
| 09/25/2001 | US6294194 Improving mass transfer rates, removing soluble compositions from materials. such as capsule mold lubricants, residual solvents, and contaminants from chemical and pharmaceutical containers and preparations, repeatedly modulating the |
| 09/25/2001 | US6294169 Interleukin-1 beta converting enzyme like apoptotic protease-6 |
| 09/25/2001 | CA2214601C Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 09/25/2001 | CA1341298C Human serum albumin fragment |
| 09/25/2001 | CA1341296C 2-azabicycloalkane-3-carboxylic acid derivatives, processes for their preparation, agents containing these compounds and their use |
| 09/20/2001 | WO2001069261A2 Proteins, genes and their use for diagnosis and treatment of vascular dementia |
| 09/20/2001 | WO2001069252A1 Methods and compositions for the regulation of vasoconstriction |
| 09/20/2001 | WO2001068880A2 Estrogen-regulated myo-inositol phosphate synthase: compositions and methods of use |
| 09/20/2001 | WO2001068862A1 Insulin homolog polypeptide zins4 |
| 09/20/2001 | WO2001068860A1 Antibodies to human cd154 |
| 09/20/2001 | WO2001068855A2 Gtp-binding protein gamma-12 subunit |
| 09/20/2001 | WO2001068851A2 Polypeptides and nucleic acids encoding same |
| 09/20/2001 | WO2001068839A2 Regulation of human lipoxin a4 receptor-like protein |
| 09/20/2001 | WO2001068815A1 Embryonic stem cells and neural progenitor cells derived therefrom |
| 09/20/2001 | WO2001068697A2 Methods and compositions for immunoregulation |
| 09/20/2001 | WO2001068670A2 Family of mechanically sensitive human potassium channels activated by polyunsaturated fatty acids and use thereof |
| 09/20/2001 | WO2001068653A1 Dihydroimidazo[2,1-b]thiazole and dihydro-5h-thiazolo[3,2-a]pyrimidines as antidepressant agents |
| 09/20/2001 | WO2001068643A2 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines |
| 09/20/2001 | WO2001068634A1 4-fluoroalkyl-2h-benzopyrans with anti-estrogenic activity |
| 09/20/2001 | WO2001068629A1 Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans |
| 09/20/2001 | WO2001068619A1 5-amide substituted diarylamines as mex inhibitors |
| 09/20/2001 | WO2001068612A2 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
| 09/20/2001 | WO2001068611A1 Pyridazinyl phenyl hydrazones useful against congestive heart failure |
| 09/20/2001 | WO2001068607A1 Amide compounds and use thereof |
| 09/20/2001 | WO2001068603A2 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl iv, processes for their preparation, and their use |
| 09/20/2001 | WO2001068591A1 Carboxylic acid derivatives as ip antagonists |
| 09/20/2001 | WO2001068582A1 Novel fatty acid analogous |
| 09/20/2001 | WO2001068570A2 Il-8 receptor antagonists |
| 09/20/2001 | WO2001068569A2 Il-8 receptor antagonists |
| 09/20/2001 | WO2001068568A2 Il-8 receptor antagonists |
| 09/20/2001 | WO2001068158A1 Coating that promotes endothelial cell adherence |
| 09/20/2001 | WO2001068136A1 Drugs for complications of diabetes and neuropathy and utilization thereof |
| 09/20/2001 | WO2001068120A2 Uses of bombesin receptor 3 |
| 09/20/2001 | WO2001068099A1 Modulation of cardiovascular injury |
| 09/20/2001 | WO2001068084A1 Il-8 receptor antagonists |
| 09/20/2001 | WO2001068075A2 Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 09/20/2001 | WO2001068074A2 Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds |
| 09/20/2001 | WO2001068071A2 Use of natural chrysanthone compounds having antiangiogenic activity |
| 09/20/2001 | WO2001068070A2 Use of spirolaxin for the treatment of diseases associated with abnormal angiogenesis |
| 09/20/2001 | WO2001068064A2 Use of cdp-choline for the prophylactic treatment of cerebral ischemia |
| 09/20/2001 | WO2001068055A1 Pharmaceutical compositions of glycogen phosphorylase inhibitors |